journal of lipid research calendar · 2006-09-23 · journal of lipid research calendar ... r. 1762...

J O U R N A L O F L I P I D R E S E A R C HCalendar

2006 FASEB Summer Research Conference—MolecularBiology of Intestinal Lipid Transport and MetabolismJuly 15–20, 2006, Tucson, AZ

For information contact:

http://src.faseb.org/2006/programs/AZ_03.pdf

Email: [email protected]

10th International Conference on Alzheimer’s Diseaseand Related DisordersJuly 15–20, 2006, Madrid, Spain


http://www.alz.org/icad/program_committee.asp

17th International Symposium on Plant LipidsJuly 16–21, 2006, East Lansing, MI


http://www.ispl2006.msu.edu


2006 FASEB Summer Research Conference—ProteinLipidation, Signaling, and Membrane DomainsJuly 22–27, 2006, Indian Wells, CA


http://src.faseb.org/2006/programs/IW_05.pdf


Bioscience 2006July 23–27, 2006, Glasgow, UK


http://www.bioscience2006.org/programme/default.htm

7th Congress of the International Society of Fatty Acids andLipids Incorporating the 6th International Congress onEssential Fatty Acids and Eicosanoids & PUFA in Maternaland Infant HealthJuly 23–28, 2006, Cairns, Australia


http://www.fcconventions.com.au/ISSFAL2006/

3rd Annual Symposium of the AHA Council on BasicCardiovascular Sciences: Translation of Basic Insights intoClinical PracticeJuly 31–August 3, 2006, Keystone, CO


http://www.americanheart.org/presenter.jhtml?identifier=3032066


9th Annual Scientific Forum of the SoutheastLipid AssociationAugust 11–13, 2006, Amelia Island, FL


http://www.lipid.org/chapters/sela


Kern Aspen Lipid ConferenceAugust 19–22, 2006, Aspen, CO


http://www.uchsc.edu/kernconference/


17th International Mass Spectrometry ConferenceAugust 27–September 1, 2006, Prague, Czech Republic


http://www.imsc2006.org/


Joint Symposium: Protein Design and Evolutionfor BiocatalysisAugust 30–September 1, 2006, Greifswald, Germany


http://www.chemie.uni-greifswald.de/%7Ebiotech/pdb-2006.html

World Congress of Cardiology 2006September 2–6, 2006, Barcelona, Spain


http://www.worldcardio2006.org


European Lipoprotein Club 29th Annual MeetingSeptember 4–7, 2006, Tutzing, Germany


http://www.elc-tutzing.org/

47th International Conference on the Bioscience of LipidsICBL–ELIFE–ILPS Joint MeetingSeptember 5–10, 2006, Pecs, Hungary


http://www.icbl2006.hu/

45th Annual Meeting of the Japan OilChemists’ SocietySeptember 6–8, 2006, Japan



OFI International Asia 2006September 12–14, 2006, Kuala Lumpur, Malaysia


http://www.oilsandfatsinternational.com/download/OFIC06Programme.pdf

4th Euro Fed Lipid CongressOctober 1–4, 2006, Madrid, Spain


http://www.eurofedlipid.org/meetings/madrid/index.htm


13th Annual Symposium on Atherosclerosis Prevention(Chetola Conference)October 13–14, 2006, Blowing Rock, NC


Tel.: (336) 713-7237

German Society for Fat Science (DGF): Fats andHealth—Update on Dietary Phytosterols, Trans-FattyAcids and Conjugated Linoleic AcidsOctober 19–20, 2006, Frankfurt, Germany


http://www.dgfett.de/meetings/frankfurt/index.html

Journal of Lipid Research Volume 47, 2006 1881

3rd Annual Scientific Forum of the MidwestLipid AssociationOctober 20–22, 2006, Kansas City, MO


http://www.lipid.org/chapters/mwla


FEBS Special Meeting: European Lipidomics InitiativeOctober 21–25, 2006, Noordwijkerhout, The Netherlands


http://www.febslipid2006.chem.uu.nl/

The Liver Meeting 2006 57th Annual Meeting of theAmerican Association for the Study of Liver DiseaseOctober 27–31, 2006, Boston, MA


https://www.aasld.org/eweb/DynamicPage.aspx?webcode=2006_AnnualMeeting

Second ISN Special Neurochemistry Conference: NeuralGlycoproteins and GlycolipidsDecember 1–5, 2006, Antigua, W.I.


http://www.isnantigua2006.org/

19th World Diabetes CongressDecember 3–7, 2006, Cape Town, South Africa


http://www.idf2006.org/

German Society for Fat Science (DGF): OleochemicalsUnder Changing Global ConditionsFebruary 25–27, 2007, Hamburg, Germany


http://www.dgfett.de/meetings/hamburg/index.html

3rd European Symposium on Plant LipidsApril 2–4, 2007, York, UK


http://www.eurofedlipid.org/meetings/index.htm

2nd International Congress on Prediabetes and theMetabolic SyndromeApril 25–28, 2007, Barcelona, Spain


http://www.kenes.com/prediabetes2007


European Atherosclerosis Society 76th CongressJune 10–13, 2007, Helsinki, Finland


http://www.eas-society.org

XXIst Congress of the International Society on Thrombosisand HaemostasisJuly 6–12, 2007, Geneva, Switzerland


http://www.isth2007.com

48th International Conference on the Bioscienceof LipidsSeptember 4–8, 2007, Turku, Finland


http://www.icbl2007.abo.fi

5th Euro Fed Lipid CongressSeptember 16–19, 2007, Goteborg, Sweden


http://www.eurofedlipid.org/meetings/goeteborg/index.htm

1882 Journal of Lipid Research Volume 47, 2006

Adeli, K. 1749Alemany, R. 1762Ambalavanan, N. 1844Andersson, A. 1833Aoyama, S. 1852Arai, H. 1791Avramoglu, R. K. 1749Axler, O. 1833Baamonde, C. 1762Barcelo, F. 1762Barrett, P. H. R. 1607, 1620Bell, J. M. 1812Bhattacharya, A. 1739Broedl, U. C. 1803Budreck, E. C. 1803Carey, M. C. 1780Chan, D. C. 1607Chang, L. 1812Chen, M.-Y. 1823Christoffersen, C. 1833Churchill, G. A. 1780Crouse, III, J. R. 1677Dahlback, B. 1833Das, A. K. 1874Delgado, C. 1762DeMar, Jr., J. C. 1812Eckhardt, E. R. M. 1700Egea, C. 1762Ehnholm, C. 1725Escriba, P. V. 1762Fernandes, G. 1739Gantz, D. L. 1714Glick, J. M. 1803Griffon, N. 1803Hajra, A. K. 1874Hamilton, J. A. 1714Han, X. 1865Hellerstein, M. K. 1651Hiraki, J. 1852Hirata, T. 1791

Igarashi, M. 1812Ikewaki, K. 1771Jakobs, K. H. 1762Jao, S.-C. 1823Jauhiainen, M. 1725Jensen, M. D. 1643Jiang, X. 1865Johnsen, A. H. 1833Kioka, N. 1791Klimtchuk, E. 1714Kobayashi, A. 1791Koutsari, C. 1643Kovanen, P. T. 1725Kurtz, U. 1780Lee-Rueckert, M. 1725Leonard, S. W. 1733Lewis, G. F. 1631Li, N.-q. 1844Li, R. 1780Lichtenstein, A. H. 1661Londos, C. 1859Long, C. J. 1803Lucke, C. 1714Lyons, M. A. 1780Ma, K. 1812Mann, J. 1668Marchadier, D. H. L. 1803Matsuo, M. 1791McAuley, K. 1668Metso, J. 1725Milam, J. E. 1874Minehira-Castelli, K. 1733Misasa, K. 1791Mossner, J. 1780Nielsen, L. B. 1833Paigen, B. 1780Parhofer, K. G. 1620Parks, E. J. 1651Patterson, B. W. 1631

Qiu, W. 1749Rader, D. J. 1803Rahman, M. M. 1739Rapoport, S. I. 1812Rashid, S. 1631Reddy, R. C. 1874Ross, A. C. 1844Rutledge, A. C. 1749Sacks, F. M. 1771Shetty, S. 1700Shimizu, Y. 1791Sun, B. 1700Takaichi, H. 1852Takaku, T. 1852Takanezawa, Y. 1791Teres, S. 1762Traber, M. G. 1733Tsai, J. 1749Tsay, S.-S. 1823Tsujita, T. 1852Ueda, K. 1791van der Westhuyzen, D. R. 1700Vikstedt, R. 1725Viswanadha, S. 1859Vogler, O. 1762Walker, Q. M. 1733Walsh, B. W. 1771Wang, X. 1780Watts, G. F. 1607Webb, N. R. 1700Wittenburg, H. 1780Wu, S.-H. 1823Yang, F.-L. 1823Yang, Y.-L. 1823Young, S. G. 1733Zheng, C. 1771Zolfaghari, R. 1844Zou, W. 1823


AUTHOR INDEX Volume 47, Number 8

Authors are required to submit manuscripts electronically usingthe Journal of Lipid Research Online Submission and Review Systemavailable at http://www.jlr.org/submit.Only PDF format may be sub-mitted online to JLR. All color art must be in RGB format.

ScopeThe Journal of Lipid Research ( JLR) publishes original articles

and reviews in the broadly defined area of biological lipids.Manuscripts relating to lipids, including those addressing problemsin biochemistry, molecular biology, structural biology, cell biology,genetics, molecular medicine, clinical medicine, and metabolism, areencouraged. Major criteria for acceptance of articles are new insightsinto mechanisms of lipid function and metabolism and/or genes reg-ulating lipid metabolism along with sound primary experimentaldata. Interpretation of the data is the authors’ responsibility, andspeculation should be labeled as such. Manuscripts that provide newways of purifying, identifying, and quantifying lipids are invited forthe Methods section of the Journal. Because JLR has worldwide distri-bution, it encourages contributions from investigators in all coun-tries, but articles must be submitted in clear and concise English.

Prior PublicationThe JLR publishes original and review articles. Except for re-

view articles, the JLR will not publish articles in which a significantportion of the data, in the form of text, figures, and tables, hasbeen published or submitted for publication elsewhere. In accor-dance with this policy, the JLR requires that the authors state, intheir cover letter, that no significant amount of data reported intheir manuscript has been published elsewhere or is under consid-eration for publication elsewhere. If some of the data presented inthe manuscript have been previously published, or such is contem-plated, a reprint or a copy of the manuscript must accompany thearticle. If, in the Editor’s judgment, the prior publication rendersthe submitted article nonoriginal, the manuscript will be returnedto the authors immediately, without review.

Studies Involving Human Subjects and Patient-Oriented ResearchThe research described in papers submitted to JLR, including

patient-oriented research articles, that involve the use of human beings,must adhere to the principles of the Declaration of Helsinki (seehttp://www.wma.net/e/policy/b3.htm), as well as to Title 45, US Codeof Federal Regulations, Part 46, Protection of Human Subjects, RevisedNovember 13, 2001, effective December 13, 2001 (see http://hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm). These studies must beapproved by an appropriate Institutional Review Board or Committee,and informed consent must be obtained from the human subjects ortheir representatives. If registration of clinical studies is required inaccord with the International Committee of Medical Journal Editors(ICMJE) (see http://prsinfo. clinicaltrials.gov/icmje.html and http://www.icmje.org), then such registration must be indicated in a footnotein the manuscript.

The Methods section of the paper must include: 1) a statement ofprotocol approval from an Institutional Review Board or Committeeand 2) a statement that informed consent was obtained from thehuman subjects or their representatives.

Ethical Use of Animals in ResearchAll investigations involving animals that are reported in manu-

scripts submitted to JLR must be conducted in conformity with thePublic Health Service (PHS) Policy on Humane Care and Use ofLaboratory Animals, incorporated in the Institute for LaboratoryAnimal Research (ILAR) Guide for Care and Use of LaboratoryAnimals (see http://dels.nas.edu/ilar_n/ilarhome/guide.shtml). Allsuch investigations must be approved by an appropriate InstitutionalReview Board or Committee.

All papers submitted to JLR that include investigations involvinganimals must include in the Methods section: 1) a statement indicatingthat the research was conducted in conformity with this PHS policyand 2) a statement that the studies were approved by an appropriateInstitutional Review Board or Committee.

Monoclonal AntibodiesPapers in which monoclonal antibodies constitute an essential

reagent must contain a footnote indicating how a qualified investigatorcan obtain the antibody or a sample of the parent hybridoma cells.

Manuscript Categories1. Full-length regular research articles. Such articles present origi-

nal research and address a clearly stated specific hypothesis or ques-tion. Papers should provide novel approaches and new insights intothe problem addressed. Manuscripts dealing with mechanisms areespecially encouraged.

Review process. Manuscripts are assigned to Associate Editors orEditorial Board members, who determine whether methods are

adequate and if data support the conclusions drawn and providenew and exciting information that is of the high quality expected byJLR. Papers generally will be assigned to at least two reviewers inaddition to the Associate Editor, and the final determination ofpublication will be made by the Associate Editor in consultationwith the Editorial Board.

2. Short Communications. Such manuscripts must be hypothesisdriven, highly original and innovative, and address a problem of broadappeal to the readership. The papers must be brief and to the point.Authors should include in the cover letter a clear statement that thework is being submitted as a Short Communication. A maximum offour printed pages in the Journal will be allocated to each ShortCommunication. As a general guideline, the abstract should be limitedto about 150 words, the text to no more than 2000 words, the maxi-mum number of combined tables and figures to no more than four,and the number of references to no more than 25. The size of each ofthese components can vary, as long as the entire presentation does notexceed the limit of four printed pages in the Journal. Submissions thatare judged by the Editor to be too long will be returned without review.

Review process. The Editor and an Associate Editor will review thepaper. In addition to the quality of the work, the article will bejudged on novelty, importance of the data, and the value of makingthe information available to the lipid research community on anaccelerated basis. Review is expedited and papers will appear in thenext available issue.

3. Methods papers. The editors will consider significant new/novel contributions in the field of lipid methodology; the papermust provide sufficient details so that the method can be readilyreproduced. These papers should be short and concise. At the timeof submission the authors should indicate that the manuscript is aMethods manuscript.

Review process. Similar to that of a full-length regular research article.4. Review articles. The Journal welcomes critical reviews on cur-

rent, timely topics. Reviews should be concise and should provide abalanced analysis and summary of the topic. The information shouldbe understandable to scientists in other related fields. A good andcritical review will develop new insights into the field and proposepotential new research opportunities.

Review process. Reviews need to stand up to the scrutiny of expertsin the field; the manuscripts will be reviewed by an Associate Editorand at least one member of the Editorial Board.

5. Reports. Short reports (max 2,000 words) of special interest, suchas conference summaries of immediate importance, nomenclature,and timely information, will be considered for publication.

Review process. Subject to approval by the Editor and Deputy Editorfor relevance and timeliness, these will be reviewed by an AssociateEditor and/or at least one member of the Editorial Board.

6. Patient-oriented research articles. Such articles will includestudies in which human subjects play an important role and where atleast one of the authors has had direct contact with the subjects. Forexample, a study where a perturbation is used to gain mechanistic orclinically relevant information would meet the criteria. It does notmatter if the samples (blood, other fluids, tissue, cells) derived fromthe subjects in the study are subsequently used in an in vivo, ex vivo,or in vitro analysis (for example, the incubation of lipoproteins withcells). What does matter is that the results be linked to characteristicsof the human sources of the samples (individuals or groups) and thatsomeone on the investigatory team has actually seen the patients (asopposed to blood or tissue from a blood bank or tissue bank). Forexample, genetic studies where participants are seen by one of theauthors and where either baseline or pre- and post-perturbation bio-chemical, biophysical, and/or demographic data obtained meet thecriteria. In summary, papers appearing in the Patient-OrientedResearch category must have some link to particular human charac-teristics. These manuscripts must include a statement of institutionalapproval of the study and informed consent of the participants.

Review process. Manuscripts are assigned to Associate Editors orEditorial Board Members who determine whether methods are ade-quate and if data support the conclusions drawn and provide new andexciting information that is of the high quality expected by JLR. Paperswill generally be assigned to at least two reviewers in addition to theAssociate Editor, and the final determination of publication will bemade by the Associate Editor in consultation with the Editorial Board.

Charges to AuthorsThere is a per -page charge for all published manuscripts of

US$55, as well as a charge of US$450 per color figure. (Note: whenusing the electronic submission system, any figure submitted incolor will be reviewed and processed with the understanding thatthe figure will be published in color.)

INSTRUCTIONS TO AUTHORS

1884 Journal of Lipid Research Volume 47, 2006

Manuscript PreparationInstructions are to be followed exactly to avoid delay of the manu-

script review process. Manuscripts must be submitted electronically atthe submission site (www.jlr.org/submit), where there are easy-to-followinstructions for registering and submitting a manuscript. Submissiononline must be in PDF format (maximum size 5 MB), with text, tables,and figures in one file, and the figure number clearly displayed on eachfigure. Inclusion of an E-mail address is essential for all communica-tion, and the proofs will be sent electronically via E-mail.

Please note that, if accepted, JLR will automatically publish theaccepted version of the manuscript online as a JLR Paper in Press (inPDF format), without copyediting or typesetting. Therefore, it is crit-ical that the manuscript should be prepared with great care beforesubmitting online. It is particularly important that the title andauthors be correct, since this information will become part of thepaper’s permanent record in Medline (for further informationregarding JLR Papers in Press, please refer to the JLR web site athttp://www.jlr.org).

Cover letter. A cover letter must accompany the manuscript andshould include a statement regarding prior publication (see PriorPublication above). Authors must also indicate in the cover letter ifall listed authors have not seen and approved the manuscript as sub-mitted, with an explanation as to why, e.g., deceased author orauthor unreachable out of country, etc.

To expedite the review process, authors are encouraged to submitthe names and E-mail addresses of four or five potential reviewers.Please also indicate in the cover letter if supplemental material (forpublication online only) or material related to the manuscript andintended for the reviewers only is being submitted with the manu-script. The cover letter must be prepared in plain unformatted text,ready to be copied and pasted or typed directly into the web site. Thecover letter must not be included in the body of the manuscript.

Organization of the ManuscriptText and Tables. The text and tables should be prepared using

Microsoft Word (version 6.0 or later) and should contain the follow-ing sections in the order listed: 1) title page, 2) abstract and supple-mentary key words, 3) main text, 4) acknowledgments and notice ofgrant support (if appropriate), 5) references, 6) footnotes to text (ifany), 7) figure legends, and 8) tables. Each section must begin on anew page, and all pages must be numbered consecutively. Figuresshould not be included with the text.

Title page. The title should fit on two printed lines (about 110characters including spaces). The title page should include title,author(s), institution from which the manuscript is submitted,abbreviated title for a running footline (maximum of 60 charactersincluding spaces), and all contact information for the correspondingauthor (mailing address, telephone and fax numbers, and E-mailaddress). Footnotes to title page and to text should be kept to a mini-mum, numbered consecutively, and printed on a separate page.

Abbreviations and terminology. Please refer to the publishedabbreviation list (http://www.jlr.org/misc/JLRabbrevlist.pdf) forthose standard abbreviations that may be used without definition inJLR . All other abbreviations should be listed and explained in anunnumbered footnote on the title page. Single letter abbreviationsare discouraged. Abbreviated terms should be defined on first occur-rence in the abstract and text.

For common abbreviations and other points of style, JLR followsthe conventions of Scientific Style and Format, The CBE Manual forAuthors, Editors, and Publishers, 1994, 6th edition, prepared bythe Council of Biology Editors, Inc., and published for the Councilof Biology Editors by the Press Syndicate of the University ofCambridge, New York; Nomenclature of Lipids (Recommendations1976), IUPAC-IUB Commission of Biochemical Nomenclature. J. LipidRes. 1978. 19: 114 –128; for chemical nomenclature, Chemical Abstracts;and for enzyme terminology, Enzyme Nomenclature, Recommendations(1992) of the Nomeclature Committee of the International Union of Biochemistry and Molecular Biology, Academic Press, Inc., New York.

Abstract. An abstract, maximum 200 words, should precede eacharticle. It should state objectives, newly observed findings, and theconclusions drawn from these observations. The abstract should notcontain reference numbers. At the end of the abstract there shouldbe a short conclusion of not more than two or three sentences.

The abstract must also be copied and pasted or typed directly intothe web site (in plain unformatted text).

Supplementary key words. Up to 10 supplementary key words orphrases should be appended to every abstract. Key words should notappear in the title or running footline.

Tables. Tables should be prepared using the Table feature ofMicrosoft Word and should be placed at the end of the text file. Eachtable (one per page) should have a descriptive title and should beprepared double-spaced and numbered with Arabic figures. Tablesshould be intelligible without reference to the text. Table footnotesshould be indicated by superscripted lowercase italic letters.

Figures. The figure number must be clearly displayed on each fig-ure submitted in the PDF. The number of illustrations should be keptto a minimum, and figures should be intelligible without reference tothe text. Most charts and graphs will be reduced to fit a single column.For the printed page, final column widths are: single column, 3.25inches; double column, 7 inches. Final height for figures and their textlegends should not exceed 9.5 inches. When preparing figures pleasenote: all lines must be bold, avoid hairlines, and use Helvetica fontwhen possible.

Figure files for accepted manuscripts.All color art must be in RGB format. When saving, always embed

any ICC profile you have been working with.If a manuscript is accepted, high-resolution digital files (a separate

file for each figure) will be required for print and online publication.For information about producing quality figures, go to our printer’swebsite: http://dx.sheridan.com.

Line art. Vector EPS files are preferred for line art. Otherwise,raster EPS or TIFF files may be submitted and should have a mini-mum of 1,000 dpi resolution. All lines must be bold, and hairlinesshould be avoided.

Halftones and color. Digital files should be supplied in TIFF formatwith a minimum resolution of 300 dpi (for figures without type orlettering) or 600 dpi (for figures with type or lettering).

References. Responsibility for the accuracy of the references lies solely with the author(s). References should be numbered consecutively (in parentheses) in the order in which they arecited in the text. The reference list should be double-spaced andbegin on a new page. All authors, titles, and inclusive pages are to be listed (“et al.” is not acceptable and will result in a delay incopyediting). Unpublished observations, personal communications,or papers submitted for publication should not be included in thereference list, but should appear parenthetically in the text, and thenames and initials of all authors must be provided. Written approvalby the person(s) cited in personal communications must accompanythe manuscript. “In press” papers may appear in the reference listwith the words “In press” in place of the volume number and pagerange. Submit a PDF file of “In press” articles with the manuscript.References to abstracts are permitted when the abstract is the solesource of the information. Abbreviations of journals should conformto those used in Index Medicus, National Library of Medicine. The fol-lowing style is to be used:

Journal articles: First author’s last name, initials, second author’s ini-tials, last name, etc. Year. Title of article. Name of Journal. Volume: inclu-sive pages. (Example: Burstein, M., H. R. Scholnick, and R. Morfin.1970. Rapid method for isolation of lipoproteins from human serumby precipitation with polyanions. J. Lipid Res. 11: 583–595.)

Books: Authors’ names as above. Year. Title of Book. Publisher,City, State. Inclusive pages cited. (Example: Snedecor, G. W., and W. G.Cochran. 1967. Statistical Methods. 6th ed. Iowa State University Press,Ames, IA. 342–343.)

Articles in Books: Authors’ names as above. Year. Title of article.In Title of Book. Initials and last name(s) of editor(s). Publisher,City, State. Inclusive pages of article. (Example: Sweeley, C. C., andG. Dawson. 1969. Lipids of the erythrocyte. In Red Cell Membrane.G. A. Jamieson and T. W. Greenwalt, editors. J. B. Lippincott,Philadelphia, PA. 172–228.)

Supplemental DataSupplemental material, including Quick Time videos, may be

submitted for inclusion in the online version of JLR. Such sup-plementary material will be reviewed as part of the manuscript.Files may be prepared in any format, but text, figures, and tablesmust be converted to PDF format before submission.

Publications Office in BethesdaIf it is not possible to submit a manuscript online, please contact the

JLR Publications Office below for other options. Questions related toonline submission, copyediting, proofs, reprints, copyright, subscrip-tions, etc. should be addressed to Virginia Bourgeois, Peer ReviewManager, 9650 Rockville Pike, Bethesda, Maryland 20814-3998. Phone:301-634-7106; fax: 301-634-7129; E-mail: [email protected].


We’re experts in our industries and professions. We work in the areas of biochemistry, molecular biology, pharmacology, physiology, nutrition, anatomy and proteomics. We come from diverse backgrounds and have dedicated our professional lives to working in the biological and molecular biology fields.

Publications• Receive FREE individual subscriptions to JBC & MCP (online only)• FREE print subscription to ASBMB Today (our monthly member magazine) • Discounted rates on many scientific journals such as: Journal of Lipid

Research (print only), Trends in Biochemical Sciences, Biotechnology & Applied Biochemistry

Meetings• Discounted ASBMB Annual Meeting registration fees• Discounted ASBMB sponsored symposia registration fees• Access to Fellowship Travel Awards, Career Networking and

Employment Assistance.

Advocacy• Become involved in all levels of governmental activities• Attend special symposia on exciting topics like Evolution• Stay connected with areas of legislation that relate to research with our

online resources.

Education• Annual meeting symposia sponsored by the Education & Professional

Development Committee • Free access to all the resources the ASBMB Undergraduate Affiliate

Network offers• Access to the ASBMB Annual Undergraduate Poster Competition• Links to more educational resources available at www.asbmb.org• Undergrads…join now and become an ASBMB member for only

$20.00 USD!

Diversity• Special Annual meeting symposia sponsored by the

Minority Affairs Committee• FASEB/MARC Visiting Scientists Referral Network• Access to Minority Travel Awards.

Want more information? Visit our Web site at

www.asbmb.orgor call us at 301-634-7145 for further membership information.

Why join ASBMB?

just like you.12,000 People

We are your peers.

Be the first to publish your clinical patient-oriented research paper in the Journal of Lipid Research (JLR). This new and exciting

section launched in August 2006 with a thematic review series dedicated to Patient-Oriented Research.

Here are the thematic review topics in this series:· Design and Analysis of Tracer Kinetic Studies in Humans· What We Have Learned About VLDL and LDL Metabolism From Kinetic Studies in Humans· What We Have Learned About HDL Metabolism From Kinetic Studies in Humans· Free Fatty Acid Metabolism In Human Obesity· Fats, Carbohydrates, and Proteins: Effects on Plasma Lipids· Dietary Effects on Insulin Resistance· Imaging Atherosclerosis: The State of The Art· Liver Triacylglycerol and Fatty Acid Metabolism Using Stable Isotope Precursors

For full details on how to submit your paper please visit www.jlr.org and click the link Instructions to Authors.

A New & Exciting Section In JLR!

NEW CATIONIC CERAMIDE ANALOG FROM AVANTI

®NEW CATIONIC CERAMIDE ANALOG FROM AVANTI

®

Email [email protected] or visit www.avantilipids.com

Avanti® now offers a new positively charged ceramide that readily accumulates in isolated and in situ mitochondria. Accumulated, positively charged ceramide increases inner membrane permeability and triggers release of mitochondrial cytochrome. With high solubility and bioavailability C6-Pyr-Cer may lead to the development of new therapeutic strategies that target telomerase for the treatment of HNSCC.

References• Novgorodov, S.A., Z.M. Szulc, C. Luberto, J.A. Jones, J. Bielawski, A. Bielawska, Y.A. Hannun, and L.M. Obeid. (2005). Positively charged ceramide is a potent inducer of mitochondrial permeabilization. J Biol Chem 280:16096-105.• Rossi, M.J., K. Sundararaj, S. Koybasi, M.S. Phillips, Z.M. Szulc, A. Bielawska, T.A. Day, L.M. Obeid, Y.A. Hannun, and B. Ogretmen. (2005). Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132:55-62

Now in Stock at AvantiD-erythro-2-N-[6’-(1’-pyridinium)-hexanoyl]-sphingosine bromideAvanti Number 857450

journal of lipid research calendar · 2006-09-23 · journal of lipid research calendar ... r. 1762...

Documents